Dr. Reddy's Laboratories announced the signing of a deal to divest certain non-core brands of the company in the dermatology segments to Eris Lifesciences.
Under the agreement, Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore. As per IQVIA MAT December 2022, the divested portfolio saw sales of Rs. 60 crore in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
